期刊文献+

TCT联合Cervista HPV检测在宫颈癌防治中的应用 被引量:1

在线阅读 下载PDF
导出
摘要 目的:探讨TCT联合Cervista HPV检测对宫颈癌早期筛查的价值。方法:对1032例宫颈异常女性进行TCT联合Cervista HPV检测,对高危型HPV阳性且TCT≥ASCUS者行阴道镜下活检,分析诊断价值。结果:高危型HPV阳性且TCT检出≥ASCUS 107例;活检确诊为NILM 3例,CINⅠ级33例,CINⅡ级41例,CINⅢ级25例,SCC 5例;TCT联合Cervista HPV检测对≥CINⅡ级病变检测的敏感性、特异性分别为95.78%、100.00%。结论:TCT联合Cervista HPV检测对宫颈癌的筛查有较高的应用价值。
作者 李红梅
出处 《中国高等医学教育》 2015年第1期133-134,共2页 China Higher Medical Education
  • 相关文献

参考文献3

二级参考文献33

  • 1Clifford GM, Rana RK, Franceschi S, et al. Human papillomavirus genotype distribution in low-grade cervical lesions:comparison by geographic region and with cervical cancer[J]. Cancer Epidemiol Biomarkers Prey, 2005, 14 (5) :1157-1164.
  • 2Khan MJ,Castle PE,Lorincz AT,et al. The elevated 10- year risk of cervical precancer and cancer in women with human papillomavirus(HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice [J]. J Natl Cancer Inst,2005,97(14) :1072-1079.
  • 3Kjaer SK,van den Brule AJ, Paull G, et al. Type specific persistence of high risk human papillomavirus(HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women:population based prospective follow up study[J]. BMJ, 2002,325 (7364) : 572.
  • 4Wright TC Jr,Massad LS,Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnor- mal cervical cancer screening tests[J]. Am J Obstet Gynecot,2007,197(4) :346-355.
  • 5Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined signifieance: baseline results from a randomized trial[J]. J Natl Cancer Inst, 2001,93 (4) :293-299.
  • 6Arbyn M,Buntinx F,Van Ranst M,et al. Virologic versus cytologic triage of women with equivocal Pap smears: a recta-analysis of the accuracy to detect high-grade intraepithelial neoplasia[J]. J Natl Cancer Inst, 2004,96 (4) : 280- 293.
  • 7Jordan J, Arbyn M, Martin-Hirsch P, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1 [J]. Cytopathology, 2008,19 (6) :342-354.
  • 8Nobbenhuis MA, Meijer CJ, van den Brule AJ, et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia[J]. Br J Cancer, 2001,84 (6) : 796- 801.
  • 9Wright TC Jr, Massad LS,Dunton CJ, et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ[J]. Am J Obstet Gynecol, 2007,197 (4):340-345.
  • 10Paraskevaidis E, Arbyn M, Sotiriadis A, et al. The role of HPV DNA testing in the follow-up period after treatment for CIN:a systematic review of the literature[J]. Cancer Treat Rev,2004,30(2) :205-211.

共引文献50

同被引文献10

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部